University of Birmingham > Talks@bham > School of Chemistry Seminars > MSC Seminar: The Development of a Commercial Synthesis of Avibactam: a Novel β-lactamase Inhibitor Extending the Utility of β-lactam Antibiotics in Life Threatening Infections

MSC Seminar: The Development of a Commercial Synthesis of Avibactam: a Novel β-lactamase Inhibitor Extending the Utility of β-lactam Antibiotics in Life Threatening Infections

Add to your list(s) Download to your calendar using vCal

  • UserDr John Pavey, Antibiotics Business Unit, AstraZeneca
  • ClockTuesday 31 January 2017, 14:00-15:00
  • HouseBiosciences NG08.

If you have a question about this talk, please contact Dr Dwaipayan Chakrabarti.

MSC Seminar hosted by Dr Liam Cox

Abstract not available

This talk is part of the School of Chemistry Seminars series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

 

Talks@bham, University of Birmingham. Contact Us | Help and Documentation | Privacy and Publicity.
talks@bham is based on talks.cam from the University of Cambridge.